Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin oncology device company developing at-home scalp cooling to prevent chemo hair loss; $22M YC and 8VC-backed with $15M Atlantic Bridge Series A pursuing FDA clearance for at-home oncology care model.
Luminate Medical is a Dublin, Ireland-based healthcare technology company developing patient-centered oncology care devices — most notably a next-generation scalp cooling system that prevents or reduces chemotherapy-induced hair loss (alopecia), one of the most psychologically distressing side effects of cancer treatment. Backed by Y Combinator, 8VC, and Atlantic Bridge with $22 million raised total including a $15 million Series A led by Atlantic Bridge in 2024 and a €6.4 million Irish Government grant in 2025, Luminate is pursuing FDA clearance for US market entry with first commercial revenues expected in 2025.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.